BIOMARKERS IN SERUM, URIC ACID AS A RISK FACTOR FOR TYPE 2 DIABETES ASSOCIATED WITH HYPERTENSION
Abstract
ABSTRACT
Objectives: Uric acid (UA) is the end product of purine metabolism in humans. UA is the final oxidation product of purine catabolism and has been
implicated in diabetes mellitus (DM) as well as in hyperlipidemias. Hyperuricemia can cause serious health problems including renal insufficiency.
Hyperuricemia is associated with many diseases including hypertension (HTN), DM, hypertriglyceridemia, and obesity. The aim was to determine the
serum UA (SUA) level in Patients of Type 2 DM with HTN.
Methods: Out of 100 samples, 50 were found as cases of Type 2 diabetic with HTN, and the 50 control samples were without Type 2 diabetic HTN.
Results: SUA, glycosylated hemoglobin, and low-density lipoprotein of male and female cases of Type 2 DM with HTN compared to control were
(p<0.05) highly significant and also serum triglycerides and total cholesterol of both sex groups of Type 2 DM with HTN compared to control were
found to be (p<0.05) highly significance.
Conclusion: It is concluded from our present study that level of SUA >7.0 mg/dl were significantly seen in cases of diabetes with HTN. SUA ≤5.0 mg/dl
was significantly seen in subjects without diabetes with HTN. Our data showed hyperuricemia and glycated hemoglobin as significant risk factors in
the progression of DM, atherosclerosis, myocardial infarction, renal disorder, hypertriglyceridemia, and obesity. Further large sample size studies are
needed to be done in the direction with more focused mechanistic approaches to fortify the fact. Very little is known about the relationship between
UA, DM, and HTN in India.
Keywords: Diabetes mellitus, Hypertension, Uric acid, Glycosylated hemoglobin, Lipid profile
Downloads
References
REFERENCES
American Diabetes Association. Diagnosis and classification of
diabetes mellitus. Diabetes Care 2009;32 Suppl 1:S62-7.
Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum
uric acid level and long-term incidence of hypertension: Populationbased
cohort study.
J Hum Hypertens 2006;20(12):937-45.
Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA.
Serum uric acid. Its relationship to coronary heart disease risk factors
and cardiovascular disease, Evans County, Georgia. Arch Intern Med
;132(3):401-10.
Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O. Analysis of the
relationship between fasting serum uric acid and the insulin sensitivity
index in a population-based sample of 380 young healthy Caucasians.
Eur J Endocrinol 1998;138(1):63-9.
Epstein M, Sowers JR. Diabetes mellitus and hypertension.
Hypertension 1992;19(5):403-18.
National high blood pressure education program working group report
on hypertension in diabetes. Hypertension 1994;23(2):145-58.
KDOQI. KDOQI clinical practice guidelines and clinical practice
recommendations for diabetes and chronic kidney disease. Am J
Kidney Dis 2007;49 2 Suppl 2:S12-154.
Hozawa A, Folsom AR, Ibrahim H, Nieto FJ, Rosamond WD,
Shahar E. Serum uric acid and risk of ischemic stroke: the ARIC study.
Atherosclerosis 2006;187(2):401-7.
Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and
risk for cardiovascular disease and death: the Framingham heart study.
Ann Intern Med 1999;131(1):7-13.
Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB,
Schmidt MI, Chambless LE. Risk factors for progression to incident
hyperinsulinemia: the atherosclerosis risk in communities study, 19871998.
Am
J Epidemiol 2003;158(11):1058-67.
Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High
serum uric acid as a novel risk factor for Type 2 diabetes. Diabetes Care
;31(2):361-2.
Iliesiu A, Campeanu A, Dinu D. Serum uric acid and cardiovascular
disease. J Clin Med 2010;5(3):186-92.
American Diabetes Association. Diagnosis and classification of
diabetes mellitus. Diabetic Care 2012;35(1):64-71.
McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, et al.
National Clinical Guideline for Management in Primary and Secondary
Care. Type 2 Diabetes. No. 1. London: Royal College of Physicians;
p. 259.
World Health Organization Consultation. Definition, Diagnosis and
Classification of Diabetes Mellitus and its Complications. WHO/NCD/
NCS/99.2. No. 1. World Health Organization. Geneva: Department of
Non-Communicable Disease Surveillance; 1999. p. 49.
Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM.
Glycated hemoglobin: methodologies and clinical applications. Clin
Chem 1986;32 10 Suppl: B64-70.
Varly H, Gowenlock AH, Bell M. Practical Clinical Biochemistry.
ed. London: Heinemann Medical; 1980. p. 650-7.
Teitz NW. Clinical Guide to Laboratory Tests. 3
th
ed. Philadelphia,
USA: W.E. Saunders; 1995. p. 610.
rd
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic
determination of total serum cholesterol. Clin Chem 1974;20(4):470-5.
Teitz NW. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia,
USA: W.E. Saunders; 1995. p. 130.
Xiao H. Method and Composition for Determining High Density
Lipoprotein Cholesterol. Chinese Patent CN1379235A; 2002.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the
concentration of low-density lipoprotein cholesterol in plasma, without
use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.
Tietz NW, editor. Clinical Guide to Laboratory Tests. 2nd ed.
Philadelphia: W.B. Saunders; 1990. p. 566.
Bagnati M, Cristina P, Cristiana CA, Roberta B, Emanuele A, Giorgio B.
When and why a water-soluble antioxidant becomes pro-oxidant
during a copper-induced, low-density lipoprotein oxidation: A study
which was done by using uric acid. Biochem J 1999;340:143-52.
Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H,
Asian J Pharm Clin Res, Vol 9, Issue 2, 2016, 352-355
Tripathi et al.
et al. The role of serum uric acid as an antioxidant protecting against
cancer: prospective study in more than 28 000 older Austrian women.
Ann Oncol 2007;18(11):1893-7.
Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K.
Serum uric acid and risk for development of hypertension and impaired
fasting glucose or Type II diabetes in Japanese male office workers. Eur
J Epidemiol 2003;18(6):523-30.
Alam R, Verma MK, Verma P. Glycated hemoglobin as a dual
biomarker in Type 2 diabetes mellitus predicting glycemic control and
dyslipidemia risk. Int J Life Sci Sci Res 2015;1(2):62-5.
Çağlı K, Turak O, Canpolat U, Özcan F, Tok D, Mendi MA, et al.
Association of serum uric acid level with blood pressure variability
in newly diagnosed essential hypertension. J Clin Hypertens
;17(12):929-35.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.